Organizing Committee Poster Selection

Close this tab to return to the list.
A RANDOMIZED, OPEN-LABEL, EVALUATOR-BLINDED TRIAL ON THE USE OF INCOBOTULINUMTOXIN-A FOR THE TREATMENT OF MASSETERIC HYPERTROPHY: POST-THERAPY CHANGES IN THREE-DIMENSIONAL VOLUMETRIC ANALYSES
Presenting Author: Kaitlyn M. Enright
[pdf-embedder url='https://www.neurotoxins.org/wp-content/toxins/2021/posters/0133-Slides.pdf']